nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferiprone—UGT1A6—Glucuronidation—UGT2B10—melanoma	0.0527	0.196	CbGpPWpGaD
Deferiprone—Effusion—Carmustine—melanoma	0.0494	0.0676	CcSEcCtD
Deferiprone—UGT1A6—Glucuronidation—UGT2B10—melanoma	0.0427	0.159	CbGpPWpGaD
Deferiprone—Effusion—Docetaxel—melanoma	0.0318	0.0435	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—ARNT—melanoma	0.0198	0.0735	CbGpPWpGaD
Deferiprone—Fibrosis—Carmustine—melanoma	0.0181	0.0248	CcSEcCtD
Deferiprone—Multi-organ failure—Dactinomycin—melanoma	0.017	0.0233	CcSEcCtD
Deferiprone—UGT1A6—Phase II conjugation—UGT2B10—melanoma	0.0161	0.0599	CbGpPWpGaD
Deferiprone—UGT1A6—Estrogen metabolism—CYP1B1—melanoma	0.0161	0.0598	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—SLC39A12—melanoma	0.0155	0.0577	CbGpPWpGaD
Deferiprone—Periorbital oedema—Bleomycin—melanoma	0.015	0.0206	CcSEcCtD
Deferiprone—Acute respiratory distress syndrome—Docetaxel—melanoma	0.0128	0.0175	CcSEcCtD
Deferiprone—Intracranial pressure increased—Carmustine—melanoma	0.0124	0.017	CcSEcCtD
Deferiprone—Enterocolitis—Docetaxel—melanoma	0.012	0.0164	CcSEcCtD
Deferiprone—Multi-organ failure—Docetaxel—melanoma	0.0102	0.014	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—UGT2B10—melanoma	0.00943	0.0351	CbGpPWpGaD
Deferiprone—Cerebral haemorrhage—Carmustine—melanoma	0.00937	0.0128	CcSEcCtD
Deferiprone—Cerebral haemorrhage—Temozolomide—melanoma	0.00905	0.0124	CcSEcCtD
Deferiprone—UGT1A6—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.00836	0.0311	CbGpPWpGaD
Deferiprone—Hepatomegaly—Dactinomycin—melanoma	0.00783	0.0107	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CYP1B1—melanoma	0.00759	0.0282	CbGpPWpGaD
Deferiprone—UGT1A6—NRF2 pathway—EPHA2—melanoma	0.00757	0.0282	CbGpPWpGaD
Deferiprone—Atrial fibrillation—Vemurafenib—melanoma	0.00751	0.0103	CcSEcCtD
Deferiprone—Arthritis—Vemurafenib—melanoma	0.00732	0.01	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—SLC6A11—melanoma	0.00712	0.0265	CbGpPWpGaD
Deferiprone—Pain in extremity—Vemurafenib—melanoma	0.00712	0.00974	CcSEcCtD
Deferiprone—UGT1A6—Metapathway biotransformation—AKR1B10—melanoma	0.00599	0.0223	CbGpPWpGaD
Deferiprone—Photosensitivity reaction—Vemurafenib—melanoma	0.00562	0.00768	CcSEcCtD
Deferiprone—Infestation—Vemurafenib—melanoma	0.00549	0.0075	CcSEcCtD
Deferiprone—Infestation NOS—Vemurafenib—melanoma	0.00549	0.0075	CcSEcCtD
Deferiprone—Gait disturbance—Carmustine—melanoma	0.00531	0.00727	CcSEcCtD
Deferiprone—Pulmonary embolism—Carmustine—melanoma	0.00519	0.00709	CcSEcCtD
Deferiprone—Gait disturbance—Temozolomide—melanoma	0.00514	0.00702	CcSEcCtD
Deferiprone—Pulmonary embolism—Temozolomide—melanoma	0.00501	0.00686	CcSEcCtD
Deferiprone—Oedema peripheral—Vemurafenib—melanoma	0.00485	0.00664	CcSEcCtD
Deferiprone—Connective tissue disorder—Vemurafenib—melanoma	0.00484	0.00662	CcSEcCtD
Deferiprone—Sepsis—Dactinomycin—melanoma	0.00481	0.00658	CcSEcCtD
Deferiprone—Eye disorder—Vemurafenib—melanoma	0.0046	0.0063	CcSEcCtD
Deferiprone—Cardiac disorder—Vemurafenib—melanoma	0.00457	0.00625	CcSEcCtD
Deferiprone—Sepsis—Carmustine—melanoma	0.0045	0.00616	CcSEcCtD
Deferiprone—Angiopathy—Vemurafenib—melanoma	0.00447	0.00611	CcSEcCtD
Deferiprone—Mediastinal disorder—Vemurafenib—melanoma	0.00444	0.00607	CcSEcCtD
Deferiprone—Arthritis—Bleomycin—melanoma	0.00444	0.00607	CcSEcCtD
Deferiprone—Chills—Vemurafenib—melanoma	0.00442	0.00604	CcSEcCtD
Deferiprone—Malnutrition—Vemurafenib—melanoma	0.00429	0.00586	CcSEcCtD
Deferiprone—UGT1A6—Oxidative Stress—NFKB1—melanoma	0.00418	0.0156	CbGpPWpGaD
Deferiprone—Back pain—Vemurafenib—melanoma	0.00415	0.00567	CcSEcCtD
Deferiprone—Diplopia—Carmustine—melanoma	0.00376	0.00515	CcSEcCtD
Deferiprone—Arthralgia—Vemurafenib—melanoma	0.00365	0.00499	CcSEcCtD
Deferiprone—Diplopia—Temozolomide—melanoma	0.00364	0.00498	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00362	0.00496	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00362	0.00495	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—melanoma	0.00357	0.0133	CbGpPWpGaD
Deferiprone—Pancytopenia—Bleomycin—melanoma	0.00354	0.00484	CcSEcCtD
Deferiprone—Blood bilirubin increased—Docetaxel—melanoma	0.00352	0.00482	CcSEcCtD
Deferiprone—Anaphylactic shock—Vemurafenib—melanoma	0.0035	0.00479	CcSEcCtD
Deferiprone—Infection—Vemurafenib—melanoma	0.00348	0.00475	CcSEcCtD
Deferiprone—Nervous system disorder—Vemurafenib—melanoma	0.00343	0.00469	CcSEcCtD
Deferiprone—Skin disorder—Vemurafenib—melanoma	0.0034	0.00465	CcSEcCtD
Deferiprone—Dehydration—Temozolomide—melanoma	0.00338	0.00463	CcSEcCtD
Deferiprone—Pneumonia—Bleomycin—melanoma	0.00334	0.00457	CcSEcCtD
Deferiprone—Pulmonary embolism—Docetaxel—melanoma	0.00333	0.00456	CcSEcCtD
Deferiprone—Pancytopenia—Dactinomycin—melanoma	0.0033	0.00452	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00328	0.00448	CcSEcCtD
Deferiprone—Hypotension—Vemurafenib—melanoma	0.00327	0.00447	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—SLC5A5—melanoma	0.00326	0.0121	CbGpPWpGaD
Deferiprone—Neutropenia—Dactinomycin—melanoma	0.00325	0.00445	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—CDKN1B—melanoma	0.00324	0.0121	CbGpPWpGaD
Deferiprone—Alanine aminotransferase increased—Temozolomide—melanoma	0.00321	0.00439	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00319	0.00436	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—melanoma	0.00317	0.0118	CbGpPWpGaD
Deferiprone—UGT1A6—Biological oxidations—CYP17A1—melanoma	0.00314	0.0117	CbGpPWpGaD
Deferiprone—Pneumonia—Dactinomycin—melanoma	0.00312	0.00426	CcSEcCtD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP17A1—melanoma	0.0031	0.0115	CbGpPWpGaD
Deferiprone—Pancytopenia—Carmustine—melanoma	0.00309	0.00423	CcSEcCtD
Deferiprone—Neutropenia—Carmustine—melanoma	0.00304	0.00416	CcSEcCtD
Deferiprone—Decreased appetite—Vemurafenib—melanoma	0.00304	0.00416	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00302	0.00413	CcSEcCtD
Deferiprone—Fatigue—Vemurafenib—melanoma	0.00302	0.00413	CcSEcCtD
Deferiprone—Pancytopenia—Temozolomide—melanoma	0.00299	0.00408	CcSEcCtD
Deferiprone—Neutropenia—Temozolomide—melanoma	0.00294	0.00402	CcSEcCtD
Deferiprone—Pneumonia—Carmustine—melanoma	0.00292	0.00399	CcSEcCtD
Deferiprone—Agranulocytosis—Dactinomycin—melanoma	0.00289	0.00396	CcSEcCtD
Deferiprone—Sepsis—Docetaxel—melanoma	0.00289	0.00396	CcSEcCtD
Deferiprone—Photosensitivity reaction—Temozolomide—melanoma	0.00287	0.00393	CcSEcCtD
Deferiprone—Weight increased—Temozolomide—melanoma	0.00286	0.00391	CcSEcCtD
Deferiprone—Pneumonia—Temozolomide—melanoma	0.00282	0.00386	CcSEcCtD
Deferiprone—Infestation—Temozolomide—melanoma	0.0028	0.00383	CcSEcCtD
Deferiprone—Infestation NOS—Temozolomide—melanoma	0.0028	0.00383	CcSEcCtD
Deferiprone—Hepatitis—Dactinomycin—melanoma	0.00278	0.00381	CcSEcCtD
Deferiprone—Body temperature increased—Vemurafenib—melanoma	0.00277	0.00378	CcSEcCtD
Deferiprone—Pharyngitis—Dactinomycin—melanoma	0.00276	0.00378	CcSEcCtD
Deferiprone—Chills—Bleomycin—melanoma	0.00268	0.00366	CcSEcCtD
Deferiprone—Hepatobiliary disease—Temozolomide—melanoma	0.00265	0.00363	CcSEcCtD
Deferiprone—UGT1A6—Biological oxidations—CYP1B1—melanoma	0.00264	0.00983	CbGpPWpGaD
Deferiprone—UGT1A6—Metapathway biotransformation—CYP1B1—melanoma	0.00261	0.0097	CbGpPWpGaD
Deferiprone—Hypersensitivity—Vemurafenib—melanoma	0.00258	0.00353	CcSEcCtD
Deferiprone—Oedema peripheral—Carmustine—melanoma	0.00257	0.00351	CcSEcCtD
Deferiprone—Connective tissue disorder—Carmustine—melanoma	0.00256	0.0035	CcSEcCtD
Deferiprone—Atrial fibrillation—Docetaxel—melanoma	0.00255	0.00349	CcSEcCtD
Deferiprone—Hepatitis—Temozolomide—melanoma	0.00252	0.00344	CcSEcCtD
Deferiprone—Asthenia—Vemurafenib—melanoma	0.00251	0.00343	CcSEcCtD
Deferiprone—Pharyngitis—Temozolomide—melanoma	0.0025	0.00342	CcSEcCtD
Deferiprone—Chills—Dactinomycin—melanoma	0.0025	0.00342	CcSEcCtD
Deferiprone—Urinary tract disorder—Temozolomide—melanoma	0.00249	0.0034	CcSEcCtD
Deferiprone—Oedema peripheral—Temozolomide—melanoma	0.00248	0.00339	CcSEcCtD
Deferiprone—Cardiac failure—Docetaxel—melanoma	0.00248	0.00339	CcSEcCtD
Deferiprone—Pruritus—Vemurafenib—melanoma	0.00248	0.00339	CcSEcCtD
Deferiprone—Connective tissue disorder—Temozolomide—melanoma	0.00247	0.00338	CcSEcCtD
Deferiprone—Urethral disorder—Temozolomide—melanoma	0.00247	0.00337	CcSEcCtD
Deferiprone—Eye disorder—Carmustine—melanoma	0.00243	0.00333	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—EGFR—melanoma	0.00243	0.00902	CbGpPWpGaD
Deferiprone—Pain in extremity—Docetaxel—melanoma	0.00242	0.00331	CcSEcCtD
Deferiprone—UGT1A6—NRF2 pathway—HGF—melanoma	0.00241	0.00896	CbGpPWpGaD
Deferiprone—Diarrhoea—Vemurafenib—melanoma	0.00239	0.00327	CcSEcCtD
Deferiprone—Eye disorder—Temozolomide—melanoma	0.00235	0.00322	CcSEcCtD
Deferiprone—Cardiac disorder—Temozolomide—melanoma	0.00234	0.0032	CcSEcCtD
Deferiprone—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—melanoma	0.00231	0.00859	CbGpPWpGaD
Deferiprone—Angiopathy—Temozolomide—melanoma	0.00228	0.00312	CcSEcCtD
Deferiprone—Mental disorder—Carmustine—melanoma	0.00228	0.00312	CcSEcCtD
Deferiprone—Immune system disorder—Temozolomide—melanoma	0.00227	0.00311	CcSEcCtD
Deferiprone—Mediastinal disorder—Temozolomide—melanoma	0.00227	0.0031	CcSEcCtD
Deferiprone—Malnutrition—Carmustine—melanoma	0.00227	0.0031	CcSEcCtD
Deferiprone—Chills—Temozolomide—melanoma	0.00226	0.00309	CcSEcCtD
Deferiprone—Dehydration—Docetaxel—melanoma	0.00225	0.00308	CcSEcCtD
Deferiprone—Vomiting—Vemurafenib—melanoma	0.00222	0.00304	CcSEcCtD
Deferiprone—Rash—Vemurafenib—melanoma	0.00221	0.00302	CcSEcCtD
Deferiprone—Mental disorder—Temozolomide—melanoma	0.00221	0.00302	CcSEcCtD
Deferiprone—Dermatitis—Vemurafenib—melanoma	0.0022	0.00301	CcSEcCtD
Deferiprone—Back pain—Carmustine—melanoma	0.00219	0.003	CcSEcCtD
Deferiprone—Headache—Vemurafenib—melanoma	0.00219	0.003	CcSEcCtD
Deferiprone—Malnutrition—Temozolomide—melanoma	0.00219	0.003	CcSEcCtD
Deferiprone—Discomfort—Bleomycin—melanoma	0.00218	0.00299	CcSEcCtD
Deferiprone—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00218	0.00298	CcSEcCtD
Deferiprone—Alanine aminotransferase increased—Docetaxel—melanoma	0.00213	0.00292	CcSEcCtD
Deferiprone—Anaphylactic shock—Bleomycin—melanoma	0.00212	0.0029	CcSEcCtD
Deferiprone—Back pain—Temozolomide—melanoma	0.00212	0.0029	CcSEcCtD
Deferiprone—Infection—Bleomycin—melanoma	0.00211	0.00288	CcSEcCtD
Deferiprone—Nausea—Vemurafenib—melanoma	0.00208	0.00284	CcSEcCtD
Deferiprone—Discomfort—Dactinomycin—melanoma	0.00204	0.00279	CcSEcCtD
Deferiprone—Pancytopenia—Docetaxel—melanoma	0.00199	0.00272	CcSEcCtD
Deferiprone—Hypotension—Bleomycin—melanoma	0.00198	0.00271	CcSEcCtD
Deferiprone—Convulsion—Carmustine—melanoma	0.00196	0.00269	CcSEcCtD
Deferiprone—Infection—Dactinomycin—melanoma	0.00196	0.00269	CcSEcCtD
Deferiprone—Hypertension—Carmustine—melanoma	0.00196	0.00268	CcSEcCtD
Deferiprone—Neutropenia—Docetaxel—melanoma	0.00196	0.00267	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Bleomycin—melanoma	0.00193	0.00264	CcSEcCtD
Deferiprone—Weight increased—Docetaxel—melanoma	0.0019	0.0026	CcSEcCtD
Deferiprone—Convulsion—Temozolomide—melanoma	0.0019	0.0026	CcSEcCtD
Deferiprone—Hypertension—Temozolomide—melanoma	0.00189	0.00259	CcSEcCtD
Deferiprone—Pneumonia—Docetaxel—melanoma	0.00188	0.00257	CcSEcCtD
Deferiprone—Arthralgia—Temozolomide—melanoma	0.00187	0.00255	CcSEcCtD
Deferiprone—Infestation NOS—Docetaxel—melanoma	0.00186	0.00255	CcSEcCtD
Deferiprone—Infestation—Docetaxel—melanoma	0.00186	0.00255	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00185	0.00253	CcSEcCtD
Deferiprone—Discomfort—Temozolomide—melanoma	0.00184	0.00252	CcSEcCtD
Deferiprone—Decreased appetite—Bleomycin—melanoma	0.00184	0.00252	CcSEcCtD
Deferiprone—Infection—Carmustine—melanoma	0.00184	0.00251	CcSEcCtD
Deferiprone—Jaundice—Docetaxel—melanoma	0.00182	0.00249	CcSEcCtD
Deferiprone—Pain—Bleomycin—melanoma	0.00181	0.00248	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.0018	0.00246	CcSEcCtD
Deferiprone—Anaphylactic shock—Temozolomide—melanoma	0.00179	0.00245	CcSEcCtD
Deferiprone—Infection—Temozolomide—melanoma	0.00178	0.00243	CcSEcCtD
Deferiprone—Hepatobiliary disease—Docetaxel—melanoma	0.00176	0.00241	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—ACER3—melanoma	0.00176	0.00655	CbGpPWpGaD
Deferiprone—Epistaxis—Docetaxel—melanoma	0.00176	0.00241	CcSEcCtD
Deferiprone—Nervous system disorder—Temozolomide—melanoma	0.00175	0.0024	CcSEcCtD
Deferiprone—Agranulocytosis—Docetaxel—melanoma	0.00174	0.00238	CcSEcCtD
Deferiprone—Skin disorder—Temozolomide—melanoma	0.00174	0.00238	CcSEcCtD
Deferiprone—Hypotension—Carmustine—melanoma	0.00173	0.00236	CcSEcCtD
Deferiprone—Hyperhidrosis—Temozolomide—melanoma	0.00173	0.00236	CcSEcCtD
Deferiprone—Decreased appetite—Dactinomycin—melanoma	0.00172	0.00235	CcSEcCtD
Deferiprone—Fatigue—Dactinomycin—melanoma	0.0017	0.00233	CcSEcCtD
Deferiprone—Pain—Dactinomycin—melanoma	0.00169	0.00231	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Carmustine—melanoma	0.00169	0.00231	CcSEcCtD
Deferiprone—Urticaria—Bleomycin—melanoma	0.00168	0.0023	CcSEcCtD
Deferiprone—Body temperature increased—Bleomycin—melanoma	0.00168	0.00229	CcSEcCtD
Deferiprone—Hepatitis—Docetaxel—melanoma	0.00167	0.00229	CcSEcCtD
Deferiprone—Pharyngitis—Docetaxel—melanoma	0.00166	0.00227	CcSEcCtD
Deferiprone—Urinary tract disorder—Docetaxel—melanoma	0.00165	0.00226	CcSEcCtD
Deferiprone—Oedema peripheral—Docetaxel—melanoma	0.00165	0.00226	CcSEcCtD
Deferiprone—Somnolence—Carmustine—melanoma	0.00164	0.00225	CcSEcCtD
Deferiprone—Connective tissue disorder—Docetaxel—melanoma	0.00164	0.00225	CcSEcCtD
Deferiprone—Urethral disorder—Docetaxel—melanoma	0.00164	0.00224	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Temozolomide—melanoma	0.00163	0.00223	CcSEcCtD
Deferiprone—Gastrointestinal pain—Dactinomycin—melanoma	0.00162	0.00221	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—UGT2B10—melanoma	0.00161	0.00599	CbGpPWpGaD
Deferiprone—Decreased appetite—Carmustine—melanoma	0.00161	0.0022	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Carmustine—melanoma	0.0016	0.00219	CcSEcCtD
Deferiprone—Somnolence—Temozolomide—melanoma	0.00159	0.00217	CcSEcCtD
Deferiprone—Pain—Carmustine—melanoma	0.00158	0.00216	CcSEcCtD
Deferiprone—Dyspepsia—Temozolomide—melanoma	0.00157	0.00215	CcSEcCtD
Deferiprone—Eye disorder—Docetaxel—melanoma	0.00156	0.00214	CcSEcCtD
Deferiprone—Body temperature increased—Dactinomycin—melanoma	0.00156	0.00214	CcSEcCtD
Deferiprone—Abdominal pain—Dactinomycin—melanoma	0.00156	0.00214	CcSEcCtD
Deferiprone—Hypersensitivity—Bleomycin—melanoma	0.00156	0.00214	CcSEcCtD
Deferiprone—Decreased appetite—Temozolomide—melanoma	0.00155	0.00213	CcSEcCtD
Deferiprone—Cardiac disorder—Docetaxel—melanoma	0.00155	0.00212	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Temozolomide—melanoma	0.00154	0.00211	CcSEcCtD
Deferiprone—Fatigue—Temozolomide—melanoma	0.00154	0.00211	CcSEcCtD
Deferiprone—Pain—Temozolomide—melanoma	0.00153	0.00209	CcSEcCtD
Deferiprone—Asthenia—Bleomycin—melanoma	0.00152	0.00208	CcSEcCtD
Deferiprone—Angiopathy—Docetaxel—melanoma	0.00152	0.00208	CcSEcCtD
Deferiprone—Gastrointestinal pain—Carmustine—melanoma	0.00151	0.00207	CcSEcCtD
Deferiprone—Immune system disorder—Docetaxel—melanoma	0.00151	0.00207	CcSEcCtD
Deferiprone—Mediastinal disorder—Docetaxel—melanoma	0.00151	0.00206	CcSEcCtD
Deferiprone—Chills—Docetaxel—melanoma	0.0015	0.00205	CcSEcCtD
Deferiprone—Pruritus—Bleomycin—melanoma	0.0015	0.00205	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—HS3ST5—melanoma	0.0015	0.00557	CbGpPWpGaD
Deferiprone—Mental disorder—Docetaxel—melanoma	0.00147	0.00201	CcSEcCtD
Deferiprone—Body temperature increased—Carmustine—melanoma	0.00146	0.002	CcSEcCtD
Deferiprone—Abdominal pain—Carmustine—melanoma	0.00146	0.002	CcSEcCtD
Deferiprone—Gastrointestinal pain—Temozolomide—melanoma	0.00146	0.002	CcSEcCtD
Deferiprone—Malnutrition—Docetaxel—melanoma	0.00146	0.00199	CcSEcCtD
Deferiprone—Hypersensitivity—Dactinomycin—melanoma	0.00146	0.00199	CcSEcCtD
Deferiprone—Urticaria—Temozolomide—melanoma	0.00142	0.00194	CcSEcCtD
Deferiprone—Asthenia—Dactinomycin—melanoma	0.00142	0.00194	CcSEcCtD
Deferiprone—Abdominal pain—Temozolomide—melanoma	0.00141	0.00193	CcSEcCtD
Deferiprone—Body temperature increased—Temozolomide—melanoma	0.00141	0.00193	CcSEcCtD
Deferiprone—Back pain—Docetaxel—melanoma	0.00141	0.00193	CcSEcCtD
Deferiprone—Hypersensitivity—Carmustine—melanoma	0.00136	0.00186	CcSEcCtD
Deferiprone—Diarrhoea—Dactinomycin—melanoma	0.00135	0.00185	CcSEcCtD
Deferiprone—Vomiting—Bleomycin—melanoma	0.00135	0.00184	CcSEcCtD
Deferiprone—Rash—Bleomycin—melanoma	0.00134	0.00183	CcSEcCtD
Deferiprone—Dermatitis—Bleomycin—melanoma	0.00134	0.00183	CcSEcCtD
Deferiprone—Asthenia—Carmustine—melanoma	0.00133	0.00182	CcSEcCtD
Deferiprone—Hypersensitivity—Temozolomide—melanoma	0.00132	0.0018	CcSEcCtD
Deferiprone—Asthenia—Temozolomide—melanoma	0.00128	0.00175	CcSEcCtD
Deferiprone—Diarrhoea—Carmustine—melanoma	0.00127	0.00173	CcSEcCtD
Deferiprone—Pruritus—Temozolomide—melanoma	0.00127	0.00173	CcSEcCtD
Deferiprone—Convulsion—Docetaxel—melanoma	0.00126	0.00173	CcSEcCtD
Deferiprone—Nausea—Bleomycin—melanoma	0.00126	0.00172	CcSEcCtD
Deferiprone—Hypertension—Docetaxel—melanoma	0.00126	0.00172	CcSEcCtD
Deferiprone—Vomiting—Dactinomycin—melanoma	0.00126	0.00172	CcSEcCtD
Deferiprone—Rash—Dactinomycin—melanoma	0.00125	0.00171	CcSEcCtD
Deferiprone—Arthralgia—Docetaxel—melanoma	0.00124	0.0017	CcSEcCtD
Deferiprone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00123	0.00169	CcSEcCtD
Deferiprone—Diarrhoea—Temozolomide—melanoma	0.00122	0.00167	CcSEcCtD
Deferiprone—Anaphylactic shock—Docetaxel—melanoma	0.00119	0.00163	CcSEcCtD
Deferiprone—Infection—Docetaxel—melanoma	0.00118	0.00162	CcSEcCtD
Deferiprone—Vomiting—Carmustine—melanoma	0.00118	0.00161	CcSEcCtD
Deferiprone—Nausea—Dactinomycin—melanoma	0.00117	0.00161	CcSEcCtD
Deferiprone—Rash—Carmustine—melanoma	0.00117	0.0016	CcSEcCtD
Deferiprone—Nervous system disorder—Docetaxel—melanoma	0.00117	0.0016	CcSEcCtD
Deferiprone—Dermatitis—Carmustine—melanoma	0.00117	0.00159	CcSEcCtD
Deferiprone—Headache—Carmustine—melanoma	0.00116	0.00159	CcSEcCtD
Deferiprone—Skin disorder—Docetaxel—melanoma	0.00116	0.00158	CcSEcCtD
Deferiprone—Vomiting—Temozolomide—melanoma	0.00114	0.00156	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PLCB4—melanoma	0.00114	0.00422	CbGpPWpGaD
Deferiprone—Rash—Temozolomide—melanoma	0.00113	0.00154	CcSEcCtD
Deferiprone—Dermatitis—Temozolomide—melanoma	0.00113	0.00154	CcSEcCtD
Deferiprone—Headache—Temozolomide—melanoma	0.00112	0.00153	CcSEcCtD
Deferiprone—Hypotension—Docetaxel—melanoma	0.00111	0.00152	CcSEcCtD
Deferiprone—Nausea—Carmustine—melanoma	0.0011	0.0015	CcSEcCtD
Deferiprone—Musculoskeletal discomfort—Docetaxel—melanoma	0.00108	0.00148	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PIP4K2A—melanoma	0.00107	0.00397	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC6A11—melanoma	0.00107	0.00397	CbGpPWpGaD
Deferiprone—Nausea—Temozolomide—melanoma	0.00106	0.00145	CcSEcCtD
Deferiprone—Somnolence—Docetaxel—melanoma	0.00106	0.00145	CcSEcCtD
Deferiprone—Dyspepsia—Docetaxel—melanoma	0.00105	0.00143	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—MTAP—melanoma	0.00104	0.00386	CbGpPWpGaD
Deferiprone—Decreased appetite—Docetaxel—melanoma	0.00103	0.00141	CcSEcCtD
Deferiprone—Gastrointestinal disorder—Docetaxel—melanoma	0.00103	0.0014	CcSEcCtD
Deferiprone—Fatigue—Docetaxel—melanoma	0.00103	0.0014	CcSEcCtD
Deferiprone—Pain—Docetaxel—melanoma	0.00102	0.00139	CcSEcCtD
Deferiprone—Gastrointestinal pain—Docetaxel—melanoma	0.000972	0.00133	CcSEcCtD
Deferiprone—Abdominal pain—Docetaxel—melanoma	0.00094	0.00129	CcSEcCtD
Deferiprone—Body temperature increased—Docetaxel—melanoma	0.00094	0.00129	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—LUM—melanoma	0.000926	0.00344	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PHGDH—melanoma	0.000926	0.00344	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—HPSE—melanoma	0.000908	0.00338	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CUBN—melanoma	0.000891	0.00331	CbGpPWpGaD
Deferiprone—Hypersensitivity—Docetaxel—melanoma	0.000876	0.0012	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—SDHD—melanoma	0.000861	0.0032	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CSPG4—melanoma	0.000861	0.0032	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—BSG—melanoma	0.000861	0.0032	CbGpPWpGaD
Deferiprone—Asthenia—Docetaxel—melanoma	0.000853	0.00117	CcSEcCtD
Deferiprone—Pruritus—Docetaxel—melanoma	0.000841	0.00115	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—GPAM—melanoma	0.000834	0.0031	CbGpPWpGaD
Deferiprone—Diarrhoea—Docetaxel—melanoma	0.000814	0.00111	CcSEcCtD
Deferiprone—Vomiting—Docetaxel—melanoma	0.000756	0.00103	CcSEcCtD
Deferiprone—Rash—Docetaxel—melanoma	0.00075	0.00103	CcSEcCtD
Deferiprone—Dermatitis—Docetaxel—melanoma	0.000749	0.00102	CcSEcCtD
Deferiprone—Headache—Docetaxel—melanoma	0.000745	0.00102	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—PLA2G6—melanoma	0.000709	0.00264	CbGpPWpGaD
Deferiprone—Nausea—Docetaxel—melanoma	0.000706	0.000966	CcSEcCtD
Deferiprone—UGT1A6—Metabolism—VCAN—melanoma	0.000637	0.00237	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP17A1—melanoma	0.000537	0.002	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GNA11—melanoma	0.000507	0.00189	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—FASN—melanoma	0.000496	0.00185	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—SLC5A5—melanoma	0.000488	0.00182	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CD44—melanoma	0.000472	0.00175	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—GNAQ—melanoma	0.000472	0.00175	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—CYP1B1—melanoma	0.000452	0.00168	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ABCB1—melanoma	0.000372	0.00138	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PRKCA—melanoma	0.000343	0.00127	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ERCC2—melanoma	0.00034	0.00126	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CG—melanoma	0.000268	0.000998	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PPARG—melanoma	0.000259	0.000963	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CD—melanoma	0.000236	0.000877	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—ALB—melanoma	0.000233	0.000866	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CB—melanoma	0.000206	0.000765	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTGS2—melanoma	0.000204	0.000758	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PTEN—melanoma	0.000178	0.000661	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—PIK3CA—melanoma	0.000125	0.000466	CbGpPWpGaD
Deferiprone—UGT1A6—Metabolism—AKT1—melanoma	0.000102	0.000381	CbGpPWpGaD
